Early research (Phase 1)Study completedNCT00514306What this trial is testingStudy of Intermittent OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 79
Early research (Phase 1)Ended earlyNCT00906360What this trial is testingSunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+29 more National Cancer Institute (NCI) 36
Not applicableStudy completedNCT00898664What this trial is testingDNA Analysis of Tissue Samples From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT03383094What this trial is testingChemoradiation vs Immunotherapy and Radiation for Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaCancerCancer of Head and Neck+12 more Loren Mell, MD 126
Not applicableStudy completedNCT00890903What this trial is testingNon-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)Who this might be right forNon Small Cell Lung CarcinomaMetastatic Breast Cancer Pierre Fabre Pharma GmbH 62
Testing effectiveness (Phase 2)Looking for participantsNCT04198766What this trial is testingStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Who this might be right forSolid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more Inhibrx Biosciences, Inc 340
Not applicableStudy completedNCT00984074What this trial is testingMRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Abramson Cancer Center at Penn Medicine 3
Early research (Phase 1)Ended earlyNCT05631574What this trial is testingStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerWho this might be right forNon Small Cell Lung CancerPancreatic CancerColorectal Cancer+14 more Biomea Fusion Inc. 13
Testing effectiveness (Phase 2)Study completedNCT00503997What this trial is testingPemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 42
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT05283226What this trial is testingStudy to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor TherapyWho this might be right forCarcinomaRecurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma NATCO Pharma Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT02414139What this trial is testingStudy of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)Who this might be right forCarcinoma, Non-Small-Cell Lung Novartis Pharmaceuticals 373
Testing effectiveness (Phase 2)Study completedNCT01185158What this trial is testingA Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell CarcinomaWho this might be right forHead and Neck Cancer University of Chicago 46
Large-scale testing (Phase 3)Study completedNCT00002533What this trial is testingFluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerWho this might be right forHead and Neck CancerInfectionOral Complications University of Miami
Testing effectiveness (Phase 2)Study completedNCT00020189What this trial is testingFlavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck CancerThromboembolism National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02508389What this trial is testingThe Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck CancerWho this might be right forRadiation Induced Oral Mucositis Galera Therapeutics, Inc. 223
Large-scale testing (Phase 3)WithdrawnNCT04129320What this trial is testingEnoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and NeckWho this might be right forHead and Neck CancerSquamous Cell Carcinoma of Head and Neck MacroGenics
Testing effectiveness (Phase 2)Ended earlyNCT00573989What this trial is testingIntensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck CancerWho this might be right forHead and Neck Cancer Wake Forest University Health Sciences 27
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison